Improved Bladder Cancer Detection with Blue Light Cystoscopy
Author Information
Author(s): Geavlete B, Mulţescu R, Georgescu D, Jecu M, Geavlete P
Primary Institution: ‘Sf. Ioan’ Clinical Emergency Hospital, Department of Urology, Bucharest, Romania
Hypothesis
HAL fluorescence cystoscopy is a more effective diagnostic tool for non-invasive bladder tumors compared to standard white light cystoscopy.
Conclusion
HAL fluorescence cystoscopy significantly improves diagnostic accuracy and reduces short-term recurrence rates in patients with non-invasive bladder tumors.
Supporting Evidence
- WLC identified 115 tumors with a detection rate of 68.8%, while BLC identified 157 tumors with a detection rate of 94%.
- The recurrence rate for the study group was 6.4%, significantly lower than the 24.2% for the control group.
- BLC showed a diagnostic accuracy of 94% compared to 68.8% for WLC.
- 51.4% of cases diagnosed with BLC had at least one additional tumor not detected by WLC.
Takeaway
Using a special blue light helps doctors find more bladder tumors than regular light, which means patients can get better treatment.
Methodology
The study involved 70 patients diagnosed with non-invasive bladder tumors, comparing the effectiveness of white light cystoscopy and blue light cystoscopy over a follow-up period of 5 months.
Limitations
The study was limited to a one-year experience and may not account for long-term outcomes.
Participant Demographics
49 men and 21 women, mean age 66 years (range 34 to 83).
Statistical Information
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website